Lexicon Pharmaceuticals Ownership | Who Owns Lexicon Pharmaceuticals?
Lexicon Pharmaceuticals Ownership Summary
Lexicon Pharmaceuticals is owned by 4.18% institutional investors, 0.94% insiders, and 94.88% retail investors. Artal group is the largest institutional shareholder, holding 37.47% of LXRX shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 5.64% of its assets in Lexicon Pharmaceuticals shares.
LXRX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Lexicon Pharmaceuticals | 4.18% | 0.94% | 94.88% |
| Sector | Healthcare Stocks | 232.20% | 10.74% | -142.94% |
| Industry | Biotech Stocks | 382.11% | 10.55% | -292.66% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Artal group | 136.18M | 37.47% | $156.61M |
| Siren | 38.92M | 10.71% | $52.54M |
| Fmr | 38.68M | 10.65% | $52.22M |
| Blackrock | 9.89M | 4.03% | $16.62M |
| Vanguard group | 9.61M | 2.64% | $11.05M |
| Blackrock funding, inc. /de | 3.19M | 0.88% | $3.67M |
| Ubs group | 3.01M | 0.83% | $3.46M |
| Sessa capital im | 3.00M | 0.83% | $4.05M |
| Geode capital management | 2.50M | 0.69% | $2.88M |
| Cibc private wealth group | 1.95M | 0.54% | $2.24M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Artal group | 136.18M | 21.91% | $156.61M |
| Siren | 38.92M | 2.06% | $52.54M |
| Gsa capital partners llp | 996.24K | 0.10% | $1.15M |
| Sessa capital im | 3.00M | 0.10% | $4.05M |
| Hennion & walsh asset management | 901.22K | 0.04% | $1.04M |
| Cvi | 20.00K | 0.03% | $33.60K |
| R squared | 46.58K | 0.03% | $53.57K |
| Ikarian capital | 176.48K | 0.02% | $238.25K |
| Monaco asset management sam | 117.19K | 0.02% | $134.77K |
| Xtx topco | 329.54K | 0.02% | $444.87K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 3.01M | 0.00% | 2.65M |
| Blackrock | 9.89M | 0.00% | 2.20M |
| Jane street group | 1.72M | 0.00% | 1.27M |
| Goldman sachs group | 921.20K | 0.00% | 861.86K |
| Acadian asset management | 640.13K | 0.00% | 603.23K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Orbimed advisors | - | - | -11.02M |
| Point72 asset management | - | - | -8.99M |
| Schonfeld strategic advisors | 825.63K | 0.01% | -3.75M |
| Nea management company | - | - | -2.38M |
| Ameriprise financial | - | - | -2.33M |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Quadrature capital | 228.21K | 0.00% | 228.21K | $309.22K |
| Headlands | 49.65K | 0.01% | 49.65K | $67.02K |
| Cibc asset management | 39.52K | 0.00% | 39.52K | $45.45K |
| Prudential financial | 35.00K | 0.00% | 35.00K | $47.24K |
| Entrypoint capital | 33.62K | 0.02% | 33.62K | $38.66K |
Sold Out
| Holder | Change |
|---|---|
| Ifp advisors | -1.00 |
| Newedge advisors | -5.00 |
| Federated hermes | -6.00 |
| Capital performance advisors llp | -18.00 |
| Nelson, van denburg & campbell wealth management group | -21.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 31 | -76.15% | 15,205,811 | -94.10% | 4 | 0.08% | 7 | -85.11% | 8 | -80.00% |
| Sep 30, 2025 | 48 | -60.66% | 14,323,194 | -94.37% | 3 | 0.08% | 11 | -81.03% | 15 | -57.14% |
| Jun 30, 2025 | 126 | -3.82% | 256,258,970 | -3.59% | 70 | 1.31% | 59 | -11.94% | 38 | 18.75% |
| Mar 31, 2025 | 130 | -1.52% | 265,798,118 | -10.70% | 73 | 1.08% | 66 | -5.71% | 33 | 32.00% |
| Dec 31, 2024 | 122 | -12.23% | 294,769,499 | 2.13% | 81 | 1.28% | 68 | -2.86% | 20 | -4.76% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Growth Compy Commingled Pl O | 20.40M | 5.64% | 2.23M |
| Fidelity Growth Compy Commingled Pl S | 18.24M | 4.37% | 20.88K |
| Fidelity Growth Company Fund | 12.33M | 2.95% | -69.48K |
| Vanguard Total Stock Mkt Idx Inv | 6.85M | 1.64% | 1.15M |
| Vanguard US Total Market Shares ETF | 3.89M | 1.08% | - |
| Fidelity Growth Company K6 | 3.81M | 0.91% | -35.91K |
| iShares Russell 2000 ETF | 2.88M | 0.79% | - |
| Fidelity Series Growth Company | 2.90M | 0.69% | -19.40K |
| Columbia Small Cap Value I A | 1.91M | 0.53% | 497.77K |
| Vanguard Institutional Extnd Mkt Idx Tr | 1.98M | 0.47% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Feb 25, 2026 | DEBBANE RAYMOND | - | Buy | $2.98K |
| Feb 23, 2026 | DEBBANE RAYMOND | - | Buy | $147.00K |
| Feb 20, 2026 | DEBBANE RAYMOND | - | Buy | $147.79K |
| Feb 19, 2026 | DEBBANE RAYMOND | - | Buy | $71.97K |
| Feb 18, 2026 | DEBBANE RAYMOND | - | Buy | $176.47K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | 8 | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | - |
| 2024 Q4 | - | - |
| 2024 Q3 | - | - |
LXRX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools